#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune hepatitis Anti-myelin-associated glycoprotein antibodies positive Human papilloma virus immunisation Acute graft versus host disease in skin Synovial sarcoma metastatic Immunodeficiency Postprandial hypoglycaemia Netherton's syndrome Cardiac amyloidosis Lupus nephritis Squamous cell carcinoma of head and neck Arteriosclerosis Biliary neoplasm Kawasaki's disease Vascular malformation More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Diagnostics Ehlers-Danlos syndrome Hereditary motor and sensory neuropathy Encephalitis autoimmune Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Indolent systemic mastocytosis – Basic Information Alport’s syndrome – Basic Information Krabbe’s disease Retinoblastoma – Trials in Disease Congenital nephrogenic diabetes insipidus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Letrozole Tamoxifen Elezanumab SGN-ALPV Opevesostat 177Lu-Dpi-4452 Pemetrexed Disodium Nemolizumab Agrostis Stolonifera Pollen Prilocaine Eptacog Alfa (Activated) At-1501 Valganciclovir Syn321 Alirocumab Atropine Sulfate T89 Bempedoic Acid Amoxicillin Sodium Ganciclovir More therapies…

    Learn about Your Condition

    Bartonellosis Arteriosclerosis Back pain Adrenogenital syndrome Colon cancer stage III Choroidal neovascularisation Conjunctivitis Skin papilloma CADASIL Adrenocortical carcinoma Coagulopathy Liposarcoma Mantle cell lymphoma stage II Ventricular tachycardia Erdheim-Chester disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Blood Pressure Changes in Narcolepsy Patients Switching from High-Sodium Oxybate to JZP258 (Oxybate Mixed-Salt Formulation)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Calcium Oxybate
    • Magnesium Oxybate
    • Potassium Oxybate
    Belgium Czechia France Italy Spain

  • Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Follitropin Delta
    Belgium Denmark Germany Italy Spain Sweden

  • Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium France Germany Ireland Italy The Netherlands +1

  • Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Regorafenib
    • Pembrolizumab
    Belgium France Germany Italy Romania Spain

  • Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pyoderma gangrenosum
    Investigated Drugs:
    • Betamethasone
    • Cortisone Acetate
    • Triamcinolone
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium Ireland Italy The Netherlands Portugal Spain

  • Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Brimonidine Tartrate
    • Dextran 70
    • Hypromellose
    Austria Belgium Czechia Finland France Germany +7

  • Study on the Effects of Vitamin D3 in Patients with Periodontitis and Vitamin D Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Periodontitis
    Investigated Drugs:
    • Colecalciferol
    Belgium

  • Study on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apremilast
    • Deucravacitinib
    Belgium Czechia Germany Hungary Poland Spain

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Belgium Bulgaria Estonia France Greece Hungary +5
Previous Page
1 … 57 58 59 60 61 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!